NMOSD Focus Sessions
Deepen your clinical expertise with expert-led sessions on NMOSD and MOGAD. Evidence-based insights designed specifically for neurologists.
Clinical Insights into NMOSD and MOGAD
Scheduled Sessions
15/07/2026 | 15:00 (CET)
In Spanish
Session 1: Clinical-radiological features of MOGAD
Clinical-radiological features in the diagnosis of MOGAD in adults and children
Chairs Àlex Rovira & Georgina Arrambide
15:00 - 15:05
Welcome to NMOSD Focus Sessions
Xavier Montalban
Neurologist – Professor of Neurology – Cemcat, HUVH, UVic-UCC, Barcelona
15:05 - 15:25
Epidemiology and clinical-radiological features of MOGAD in adults
Álvaro Cobo-Calvo
Neurologist – Cemcat, HUVH, Barcelona
15:25 - 15:45
Epidemiología y características clínico-radiológicas de MOGAD en adultos
Álvaro Cobo-Calvo
Neurólogo – Cemcat, HUVH, Barcelona
15:05 - 15:25
Clinical-radiological features of MOGAD in children
Thaís Armangué
Neuropediatrician – Head of the Pediatric Neuroimmunology Unit, Hospital Sant Joan de Déu Barcelona, specialist in neuroimmunology and neuroinfectology – IDIBAPS/HSJD, Barcelona
15:45 - 16:00
Debate
22/07/2026 | 15:00 (CET)
In Spanish
Session 2: Seronegative NMOSD in future diagnostic criteria
Should seronegative NMOSD be maintained in the future diagnostic criteria?
Chair Álvaro Cobo-Calvo
15:00 - 15:20
Should seronegative NMOSD be maintained in the future criteria? In favour
Edgar Carnero
Neurologist – Neuroimmunology Unit, Department of Neurosciences, Hospital Alemán, Buenos Aires, Argentina
15:20 - 15:40
Should seronegative NMOSD be maintained in the new criteria? Against
Jefferson Becker
Neurologist – Professor of Neurology, Head of Neurology Service, Member of the Board – PUCRS School of Medicine, Hospital São Lucas da PUCRS, LACTRIMS, Brazil
15:40 - 16:00
Debate
02/09/2026 | 15:00 (CET)
In English
Session 3: Management of relapses in NMOSD and MOGAD
Management of relapses in NMOSD and MOGAD
Chair Álvaro Cobo-Calvo
15:00 - 15:40
Management of relapses in NMOSD and MOGAD
Paulus Rommer
Neurologist – Associate Professor – Medical University of Vienna
15:40 - 16:00
Debate
09/09/2026 | 15:00 (CET)
In English
Session 4: MRI and OCT in MOGAD and NMOSD
MRI and OCT in MOGAD and NMOSD
Chair Georgina Arrambide
15:00 - 15:20
MRI at attack and follow-up
Àlex Rovira
Neuroradiologist – Head of Neuroradiology Department – IDI, HUVH, Barcelona
15:20 - 15:40
Dynamic changes in OCT findings in NMOSD and MOGAD
Frederike C. Oertel
Neuroophthalmologist – Junior Professor for Translational Neuroimmunology – Charité's Clinical and Experimental MS Research Center, Berlin
15:40 - 16:00
Debate
16/09/2026 | 15:00 (CET)
In Spanish
Session 5: Immunosuppressive treatments for NMOSD and MOGAD
Immunosuppressive/immunomodulatory treatments for NMOSD and MOGAD
Chair Georgina Arrambide
15:00 - 15:20
NMOSD treatments
Maria Sepúlveda
Neurologist – Neuroimmunology Unit, Neurology Service, Hospital Clínic de Barcelona, Barcelona
15:20 - 15:40
MOGAD treatments
Ethel Ciampi
Neurologist – Associate Professor – Pontificia Universidad Católica de Chile, MS and Neuroimmunology Unit, Hospital Sótero del Río, Red Salud UC CHRISTUS, Chile
15:40 - 16:00
Debate
30/09/2026 | 17:00 (CET)
In Spanish
Session 6: NMO and MOGAD: essential concepts
NMO and MOGAD: essential concepts
Chairs Georgina Arrambide & Iker Elosua
17:00 - 17:20
What is MOGAD and how is it diagnosed
Iker Elosua
Neurologist – Cemcat, HUVH, Barcelona
17:20 - 17:40
What is NMOSD and how is it diagnosed
Georgina Arrambide
Neurologist – Cemcat, HUVH, Barcelona
17:40 - 18:00
Debate
Join the NMOSD Focus Sessions
Register today to gain access to exclusive live sessions, agenda highlights, and clinical updates tailored for neurology professionals.
.png){kind=logo}